Fidelis Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Buy |
5,052
+43
| +0.9% | +$5.65K | 0.06% | 228 |
|
|
2025
Q1 | $617K | Sell |
5,009
-109
| -2% | -$13.4K | 0.07% | 220 |
|
|
2024
Q4 | $706K | Sell |
5,118
-135
| -3% | -$18.6K | 0.07% | 207 |
|
|
2024
Q3 | $747K | Buy |
5,253
+409
| +8% | +$58.1K | 0.09% | 189 |
|
|
2024
Q2 | $669K | Buy |
4,844
+1,610
| +50% | +$222K | 0.1% | 176 |
|
|
2024
Q1 | $444K | Buy |
+3,234
| New | +$444K | 0.07% | 224 |
|